Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Low-dose Cyclosporine for Kidney Dysfunction in Heart Transplant Recipients
NCT00420537Phase 4Terminated
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Sep 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in Kidney disease, sponsored by Alma Mater Studiorum – Università di Bologna. Started Sep 2006; status: terminated.
02
Drugs
everolimus
03
Conditions
Kidney disease
Beyond the preview
Go deeper on NCT00420537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420537.